Reduced Intensity Conditioning Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies at High Risk for Transplant Related Mortality With Standard Transplantation.
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2009
At a glance
- Drugs Pentostatin (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 07 Jul 2009 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
- 07 Jul 2009 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 07 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.